MedTrace Logo

The Effectiveness of Bu Zhong Yi Qi Tang in Patients with Myasthenia Gravis

NCT06881173 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 112

Last updated 2025-03-20

No results posted yet for this study

Summary

Research Background: According to the Myasthenia Gravis Foundation of America (MGFA, 2015), the estimated prevalence of myasthenia gravis is 14-20 per 100,000 people, with a higher prevalence in young female individuals compared to males. However, as individuals age, especially after the age of 50, the prevalence in males becomes higher than in females. myasthenia gravis patients often experience varying degrees of disability, leading to the need for long-term medical care, medication, and lifestyle adjustments. This also gives rise to subsequent challenges in caregiving, affecting both the patients' families and society.

Conditions

Interventions

DRUG

Bu Zhong Yi Qi Tang

The experimental group took 15g of Buzhong Yiqi Decoction concentrated powder, 3 times a day, 1 packet each time.

DRUG

caramel dyed starch placebo

The control group took 15 grams of caramel dyed starch placebo, 1 pack at a time, 3 times a day.

Sponsors & Collaborators

  • Cheng, yu-ting

    lead OTHER

Principal Investigators

  • Ju-Han Liu · project leader

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-14
Primary Completion
2025-06-13
Completion
2025-06-13

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06881173 on ClinicalTrials.gov